These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35651320)

  • 1. Improving survival prediction of oesophageal cancer patients treated with external beam radiotherapy for dysphagia.
    Jeene PM; Kuijper SC; van den Boorn HG; El Sharouni SY; Braam PM; Oppedijk V; Verhoeven RHA; Hulshof MCCM; van Laarhoven HWM
    Acta Oncol; 2022 Jul; 61(7):849-855. PubMed ID: 35651320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palliative radiotherapy combined with stent insertion to reduce recurrent dysphagia in oesophageal cancer patients: the ROCS RCT.
    Adamson D; Blazeby J; Porter C; Hurt C; Griffiths G; Nelson A; Sewell B; Jones M; Svobodova M; Fitzsimmons D; Nixon L; Fitzgibbon J; Thomas S; Millin A; Crosby T; Staffurth J; Byrne A
    Health Technol Assess; 2021 May; 25(31):1-144. PubMed ID: 34042566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative radiotherapy in addition to self-expanding metal stent for improving dysphagia and survival in advanced oesophageal cancer (ROCS: Radiotherapy after Oesophageal Cancer Stenting): study protocol for a randomized controlled trial.
    Adamson D; Blazeby J; Nelson A; Hurt C; Nixon L; Fitzgibbon J; Crosby T; Staffurth J; Evans M; Kelly NH; Cohen D; Griffiths G; Byrne A
    Trials; 2014 Oct; 15():402. PubMed ID: 25336193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01).
    Penniment MG; De Ieso PB; Harvey JA; Stephens S; Au HJ; O'Callaghan CJ; Kneebone A; Ngan SY; Ward IG; Roy R; Smith JG; Nijjar T; Biagi JJ; Mulroy LA; Wong R;
    Lancet Gastroenterol Hepatol; 2018 Feb; 3(2):114-124. PubMed ID: 29248399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brachytherapy in the Palliation of Oesophageal Cancer: Effective but Impractical?
    Sinha S; Varagunam M; Park MH; Maynard ND; Trudgill N; Crosby T; Cromwell DA
    Clin Oncol (R Coll Radiol); 2019 Jul; 31(7):e87-e93. PubMed ID: 30982667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliation of malignant dysphagia from oesophageal cancer. Rotterdam Oesophageal Tumor Study Group.
    Siersema PD; Dees J; van Blankenstein M
    Scand J Gastroenterol Suppl; 1998; 225():75-84. PubMed ID: 9515757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-Course External Beam Radiotherapy Versus Brachytherapy for Palliation of Dysphagia in Esophageal Cancer: A Matched Comparison of Two Prospective Trials.
    Jeene PM; Vermeulen BD; Rozema T; Braam PM; Lips I; Muller K; van Kampen D; Homs MYV; Oppedijk V; Berbée M; van Rossum PSN; El Sharouni S; Siersema PD; Hulshof MCCM;
    J Thorac Oncol; 2020 Aug; 15(8):1361-1368. PubMed ID: 32407795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palliation of dysphagia.
    van der Bogt RD; Vermeulen BD; Reijm AN; Siersema PD; Spaander MCW
    Best Pract Res Clin Gastroenterol; 2018; 36-37():97-103. PubMed ID: 30551864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palliative short-course hypofractionated radiotherapy followed by chemotherapy in esophageal adenocarcinoma: the phase II PALAESTRA trial.
    Borg D; Sundberg J; Brun E; Kjellén E; Petersson K; Hermansson M; Johansson J; Eberhard J; Johnsson A
    Acta Oncol; 2020 Feb; 59(2):212-218. PubMed ID: 31564184
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer.
    Sur R; Donde B; Falkson C; Ahmed SN; Levin V; Nag S; Wong R; Jones G
    Brachytherapy; 2004; 3(4):191-5. PubMed ID: 15607150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palliative brachytherapy and external beam radiotherapy for dysphagia from esophageal cancer: a nationwide survey in Japan.
    Kawamoto T; Nakamura N; Saito T; Tonari A; Wada H; Harada H; Kubota H; Nagakura H; Heianna J; Miyazawa K; Yamada K; Tago M; Fushiki M; Nozaki M; Uchida N; Araki N; Sekii S; Kosugi T; Takahashi T; Shikama N
    Jpn J Clin Oncol; 2021 May; 51(6):950-955. PubMed ID: 33624768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-Dose Versus High-Dose Radiation Therapy for the Palliation of Dysphagia From Esophageal Cancer: A Multicenter Retrospective Cohort Study.
    Vermeulen BD; Jeene PM; Sijben J; Krol R; Rütten H; Bogers JA; Braam PM; Siersema PD
    Pract Radiat Oncol; 2020; 10(4):e255-e263. PubMed ID: 31669401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy enhances laser palliation of malignant dysphagia: a randomised study.
    Sargeant IR; Tobias JS; Blackman G; Thorpe S; Glover JR; Bown SG
    Gut; 1997 Mar; 40(3):362-9. PubMed ID: 9135526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of palliative interventional radiotherapy (brachytherapy) in esophageal cancer: An AIRO (Italian Association of Radiotherapy and Clinical Oncology) systematic review focused on dysphagia-free survival.
    Lancellotta V; Cellini F; Fionda B; De Sanctis V; Vidali C; Fusco V; Barbera F; Gambacorta MA; Corvò R; Magrini SM; Tagliaferri L
    Brachytherapy; 2020; 19(1):104-110. PubMed ID: 31636025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Brachytherapy for oesophageal cancer].
    Wong S; Hennequin C; Quero L
    Cancer Radiother; 2013 Apr; 17(2):159-61. PubMed ID: 23603254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WITHDRAWN: Interventions for dysphagia in oesophageal cancer.
    Sreedharan A; Harris K; Crellin A; Forman D; Everett SM
    Cochrane Database Syst Rev; 2011 Feb; (2):CD005048. PubMed ID: 21328271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for dysphagia in oesophageal cancer.
    Sreedharan A; Harris K; Crellin A; Forman D; Everett SM
    Cochrane Database Syst Rev; 2009 Oct; (4):CD005048. PubMed ID: 19821338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palliation of dysphagia in advanced, metastatic or recurrent carcinoma oesophagus with high dose rate intraluminal brachytherapy--an eastern Indian experience of 35 cases.
    Ghosh S; Sau S; Mitra S; Manna A; Ghosh K
    J Indian Med Assoc; 2012 Jul; 110(7):449-52. PubMed ID: 23520668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palliative stenting with or without radiotherapy for inoperable esophageal carcinoma: a randomized trial.
    Javed A; Pal S; Dash NR; Ahuja V; Mohanti BK; Vishnubhatla S; Sahni P; Chattopadhyay TK
    J Gastrointest Cancer; 2012 Mar; 43(1):63-9. PubMed ID: 20835926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined external beam and intracavitary radiotherapy in oesophageal carcinoma.
    Agrawal RK; Dawes PJ; Clague MB
    Clin Oncol (R Coll Radiol); 1992 Jul; 4(4):222-7. PubMed ID: 1377931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.